Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome
Condition(s):Metabolic SyndromeLast Updated:July 22, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Metabolic SyndromeLast Updated:July 22, 2013Completed
Condition(s):Type II Diabetes Mellitus; DyslipidemiaLast Updated:February 2, 2010Completed
Condition(s):Hypercholesterolemia; Dyslipidemia; Coronary Heart DiseaseLast Updated:February 2, 2010Completed
Condition(s):Hypercholesterolemia; DyslipidemiasLast Updated:March 16, 2010Completed
Condition(s):Hypercholesterolemia; DyslipidemiaLast Updated:February 2, 2010Completed
Condition(s):Hypercholesterolemia; DyslipidemiaLast Updated:January 12, 2010Completed
Condition(s):Type II Diabetes Mellitus; DyslipidemiaLast Updated:February 23, 2010Completed
Condition(s):Hypercholesterolemia; DyslipidemiaLast Updated:March 16, 2010Completed
Condition(s):Hypercholesterolemia or Combined DyslipidemiaLast Updated:March 16, 2010Completed
Condition(s):Primary Hypercholesterolemia; DyslipidemiaLast Updated:January 12, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.